Articles tagged with Cancer Screening
The UT Southwestern program identifies families with a high risk of colorectal cancer through tumor testing. Up to 50 family members can be tested for the Lynch syndrome, which carries an 80% risk of developing colon cancer.
A low-cost, hand-held device called Gene-Z is being developed to detect cancer in resource-poor countries. The device monitors microRNAs and other genetic markers to diagnose cancer, providing an affordable solution to the lack of cancer screening resources in these countries.
A single flexible sigmoidoscopy screening between ages 55-64 is associated with lower colorectal cancer (CRC) incidence and mortality. The study found that CRC incidence was reduced by 31% among those screened, and CRC mortality was significantly reduced by 38%.
Recent studies and guidelines suggest that traditional Chinese medicine may be effective in treating seasonal flu, while delayed surgery for hip fractures may not necessarily lead to poor outcomes. Additionally, new guidelines from the USPSTF recommend against bladder cancer screening in asymptomatic adults due to inadequate evidence. ...
A new urine-based test has been found to be more accurate than traditional prostate cancer screening methods, detecting the disease in 100% of cases while minimizing false positives. The PSA/SIA assay works by analyzing changes in PSA protein structure associated with cancer.
A study published in Archives of Dermatology found that physician-detected melanomas are thinner and more often detected in the early stage compared to patient-detected lesions. Physician-based screening was associated with a higher overall patient-detection rate, with most lesions found by patients due to changes in appearance.
Research found substantial changes in cancer family history between ages 30-50, leading to recommendations for earlier or more intense screening. Updates to family history should occur every 5-10 years to inform risk assessments and screening guidelines.
A study found that changes in family history of cancer can significantly alter screening recommendations, particularly for colorectal, breast, and prostate cancers. For patients aged 30-50, the risk of increased cancer risk more than tripled for colorectal cancer and increased by 60% for breast cancer.
A large clinical trial found that low-dose spiral CT scanning reduced lung cancer deaths by 20% compared to chest X-ray screening. The study involved over 53,000 participants and provided conclusive evidence of the mortality benefit from CT screening.
The University of Texas M.D. Anderson Cancer Center has introduced a comprehensive lung cancer screening program to detect the disease early. With computed tomography (CT) scans, the program reduces lung cancer-specific mortality by 20%, improving health outcomes for high-risk individuals.
A clinical trial of 78,216 women found no reduction in ovarian cancer death risk with screening. Instead, screenings led to more invasive medical procedures and higher complication rates. The study suggests that annual screening may not be effective in detecting cancers early enough to reduce mortality.
A randomized, controlled trial found that patient navigators can significantly improve CRC screening rates among low-income, black, and non-English-speaking patients. The study suggests that focusing on these populations with patient navigation may be an effective approach to reducing screening disparities.
The American Cancer Society's new report highlights successes and gaps in cancer prevention efforts, including stalled declines in smoking rates and underutilized cancer screening tests. Improving these numbers will require coordinated efforts to address social, economic, and legislative factors influencing individual health behaviors.
Researchers identified a unique protein modification induced by fumarate hydratase deficiency in a rare type of cancer. This 'biological fingerprint' can be used as a biomarker to identify tumors caused by this mechanism, leading to early diagnosis and potential targeted treatments.
A study published in the Journal of the National Cancer Institute found that patient reports of family cancer history are not highly accurate. The study revealed low to moderate accuracy rates for breast, colorectal, prostate, and lung cancer diagnoses, with higher accuracy rates for first-degree relatives
A study found that colonoscopies were performed more frequently than recommended in some older Medicare beneficiaries, while others went without necessary follow-ups. The researchers suggest that closer attention to screening rates is needed to ensure the procedure is reserved for those who can benefit from it.
A study published in the Journal of the National Cancer Institute found that breast cancers discovered between screening mammograms tend to be more aggressive and have a poorer prognosis. The research compared data from women with interval cancers (detected between mammograms) to those detected during routine screening.
CTC utilization has tripled in recent years, increasing access to colorectal cancer screening, and potentially saving lives through early detection of disease. The study suggests an opportunity for more people to be screened due to CTC's alternative to conventional optical colonoscopy.
Researchers found that adults reporting workdays of 11 hours or longer had a 67 percent higher relative risk for CHD than those working 7 or 8 hours a day. Additionally, self-monitoring and self-adjustment of anticoagulant doses resulted in superior patient outcomes without an increase in major bleeding events.
A new study found that nearly half of elderly men in their seventies underwent PSA screening, while those aged 85 and older screened just as often as those in their early fifties. The high rate of unnecessary screenings may lead to complications such as incontinence and impotence.
Research suggests that PSA velocity is a poor predictor of prostate cancer and can lead to unnecessary biopsies. The study found that men with rapid rises in PSA levels did not have cancer more often than those with slower rises, highlighting the need for alternative screening methods.
PSA screening has declined in a US healthcare network following the publication of large trials and guidelines. The decline was observed among men aged 40-54, 55-74, and 75 years and older, with decreases of 3%, 2.7%, and 2.2 percentage points, respectively.
Women with a history of breast cancer have double the cancer rates as those without, according to a comprehensive study. Annual mammography screening detects second breast cancers early, but may not be as effective in detecting invasive breast cancer.
Women with prior breast cancer have lower sensitivity and specificity for detecting second cancers through mammography screening, which may lead to over- or under-diagnosis. Screening outcomes also depend on the treatment of the first cancer.
A new study found that MRI screening in women with a history of chest irradiation can detect invasive cancers missed on mammography. The addition of MRI to the screening process resulted in a 4.4% incremental cancer detection rate.
New studies reveal a low initial PSA score of 3.0 ng/ml is an appropriate minimum cut-off level for biopsy targeting those at risk, while proficiency in robotic-assisted prostate surgery requires over 1,600 surgeries to master. Dutasteride may also slow early-stage prostate cancer growth.
A new study found that repeat MRI screenings for breast cancer result in fewer false-positive results, with a cancer detection rate nearly twice as high as baseline exams. This improved detection rate reassures high-risk patients about the effectiveness of annual MRI screening.
A new study questions US Task Force recommendations for breast cancer screening, finding that starting at a younger age and screening more frequently saves more lives. The research found that women who undergo yearly mammograms between ages 40-49 have a 40% reduction in breast cancer deaths.
Physicians report time constraints and patient embarrassment as significant barriers to conducting full-body skin examinations. Dermatologists are more likely than internists and family practitioners to perform these screenings.
A £4.7m Policy Research Unit will focus on improving cancer screening and diagnosis in the UK. The team from Peninsula College of Medicine and Dentistry aims to identify key symptoms that should prompt GPs to take action, with the goal of boosting survival rates and reducing mortality.
New research from UC Davis Cancer Center found that colon cancer screening rates vary significantly across geographic regions, with African Americans and Hispanics facing lower rates. In contrast, Asian-Pacific Islanders in Hawaii had the highest screening rates among any group, suggesting potential cultural factors at play.
A new study found that regional differences in colorectal cancer testing rates among non-white groups are a major contributor to racial and ethnic disparities in screening rates. The research suggests that targeting these regional variations is key to improving overall screening rates.
Targeted messages and mailings have shown promise in increasing colorectal cancer screening rates, especially among those overdue for screenings. However, the long-term effect remains unclear due to other promotional activities and varying patient resistance.
Incorporating ovarian cancer subtypes into screening models reduces predicted mortality rates. However, catching slower-growing cancers won't significantly impact deaths compared to more lethal tumors.
Researchers found that ovarian cancer screening can only slightly reduce mortality rates, highlighting the need for prevention and better treatments. For high-risk women, targeted screening may offer more hope in reducing deaths from ovarian cancer.
A study found that transvaginal ultrasound screening can detect endometrial cancer in asymptomatic postmenopausal women with good sensitivity and specificity. The optimal cutoff for endometrial thickness was 5.15mm, detecting 80.5% of cancer cases
The Cervical Cancer-Free America program aims to raise awareness and increase screenings for cervical cancer, targeting disadvantaged communities. With the support of a $150,000 grant, Indiana will implement initiatives to reduce HPV infection rates and increase vaccination rates, ultimately aiming to eliminate cervical cancer.
A new study by Radiological Society of North America suggests that routine mammography screening in women over 40 has a very low risk of radiation-induced breast cancer. The study found that annual or biennial screening would result in few cancers and fatalities, but numerous lives saved through early detection.
A national study conducted by the National Cancer Institute found that CT scanning can reduce lung cancer deaths by 20% in former and current heavy smokers. The study, which involved over 53,000 participants, compared low-dose helical CT with standard chest X-ray screening.
A new study published in Cancer highlights the need to expand colorectal cancer screening to minority communities, particularly those without medical insurance. Offering screening at mammography visits is an effective way to generate interest and initiate the process, with 55% of participants going on to have a colonoscopy.
A study at Memorial Sloan-Kettering Cancer Center found that introducing colon cancer screening during routine mammography screening increased minority access to preventive care. The research introduced colon cancer screening to women living in Harlem, resulting in similar colonoscopy findings as the general population.
A new study shows that fatalistic thinking in Latinas may prevent them from using cancer screening services. Seven out of eleven studies found a statistically significant inverse association between fatalism and utilization of cancer screening services.
A biomarker called TCF21 has shown promise in developing a potential screening test for early-stage lung cancer. The biomarker's abnormal expression was found in over 80% of non-small-cell lung cancers, suggesting its potential as a diagnostic tool.
A new study found that only one-fifth of primary care physicians follow practice guidelines for all recommended colorectal cancer screening tests. Many clinicians overuse or underuse screening, leading to unnecessary testing and potential complications.
A significant proportion of patients with advanced cancer receive common cancer screenings, despite the limited benefit. Screening rates are higher among those with a recent history of screening and in those with higher socioeconomic status and married status.
A new study found that dieters who slept 8.5 hours per night lost 56% more body fat compared to those who slept 5.5 hours, highlighting the importance of adequate sleep for weight maintenance. Researchers also discovered that sleep restriction increased ghrelin levels, leading to increased hunger and food intake.
Researchers identified 79 microRNAs linked to bladder cancer, showing promise for early detection through existing laboratory tests. The new method measures microRNA presence or absence in bodily fluids with high accuracy, comparable to current gold standard testing.
A new trial aims to determine if taking daily doses of a fish oil extract and aspirin can shrink existing polyps and prevent new ones from forming in the bowel. If successful, this treatment could reduce the need for frequent colonoscopies in patients at risk of developing bowel cancer.
The American College of Physicians has announced that current stool DNA tests are not effective or cost-effective for colorectal cancer screening. Additionally, researchers have found that using proton pump inhibitors and clopidogrel together does not increase risk for adverse cardiovascular outcomes after a first heart attack. In anot...
A study of 43,987 men aged 55-74 found that those with low PSA levels did not have a significant reduction in prostate cancer deaths. Men with high PSA levels benefited more from screening and treatment. The results suggest that aggressive follow-up testing and treatment may not be beneficial for men with low PSA values.
A study by University of Wisconsin-Madison researchers found that traditional approaches to cancer education are ineffective for Hmong communities due to cultural differences. The team developed a new strategy based on community-participatory research, which led to a better understanding of the community's needs and perspectives.
A new study published in Psychological Science found that men are less likely to seek cancer screening when presented with misleading information about the prevalence of screening among other men. The researchers suggest that framing health messages to emphasize the benefits of screening rather than relying on relative numbers can be a...
A study published in The Journal of the National Cancer Institute found that computed tomographic colonography (CTC) screening every five years is not cost-effective if reimbursed at the same rate as colonoscopy. However, CTC would be cost-effective if it enticed 25% more individuals to screen.
A 14-year randomized controlled trial shows that prostate cancer screening significantly reduces mortality rates. The study found that men screened for prostate-specific antigen (PSA) had a lower risk of dying from prostate cancer compared to those not screened.
A recent meta-analysis found that there is no single best intervention for promoting repeat breast cancer screening with mammography. The studies were heterogeneous, differing in their conclusions about similar interventions due to a lack of standardization among interventions or different populations and settings.
The authors propose a new paradigm for breast cancer screening, shifting focus from mammography to more effective early detection methods. Behavioral interventions appear to have limited impact on repeat screening rates, and media attention highlights the flaws of current technologies.
A study estimates that 1.58 million US cancer survivors live with their 2.85 million children, and 562,000 minor children live with a parent in early cancer treatment and recovery. Most of these survivors are female, married, and under 50 years old.
Rates of cancers affecting skin appendages such as sweat glands and mammary glands are rising in the US. Incidence increased by 150% between 1978-1982 and 2002-2005, with age being a key factor.
Clinical guidelines recommend screening low-risk women every three years after age 30, but most primary care clinicians advocate for more frequent testing. Annual Pap testing has helped decrease cervical cancer burden, but cost-effectiveness models suggest overuse may increase costs with little improvement in outcomes.
A population-based study of 2,071 Hodgkin lymphoma survivors over 15 years found that many did not receive recommended cancer screening tests. Despite frequent contact with doctors and primary care providers, survivors often lacked screenings for other cancers, including colorectal, breast, and cervical cancer.